<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref7">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Baranovich</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Jones</surname>
    <given-names>J. C.</given-names>
   </name>
   <name>
    <surname>Russier</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Szretter</surname>
    <given-names>K. J.</given-names>
   </name>
   <name>
    <surname>Sloan</surname>
    <given-names>S. E.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2016</year>). 
  <article-title>The Hemagglutinin stem-binding monoclonal antibody VIS410 controls influenza virus-induced acute respiratory distress syndrome</article-title>. 
  <source>Antimicrob. Agents Chemother.</source>
  <volume>60</volume>, 
  <fpage>2118</fpage>â€“
  <lpage>2131</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.02457-15</pub-id>, PMID: 
  <?supplied-pmid 26787699?>
  <pub-id pub-id-type="pmid">26787699</pub-id>
 </mixed-citation>
</ref>
